Thromb Haemost 2014; 111(04): 647-655
DOI: 10.1160/TH13-09-0769
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles

Mary E. W. Collier
1   Biomedical Section, Department of Biological Sciences, University of Hull, Hull, UK
,
Anthony Maraveyas
2   Division of Cancer, in association with Hull York Medical School, University of Hull, Hull, UK
,
Camille Ettelaie
1   Biomedical Section, Department of Biological Sciences, University of Hull, Hull, UK
› Author Affiliations
Financial support: This work was supported in part by Castle Hill Hospital Cancer Charity and Help-4-Health.
Further Information

Publication History

Received: 18 September 2013

Accepted after major revision: 23 October 2013

Publication Date:
29 November 2017 (online)

Summary

We previously reported that the incorporation of tissue factor (TF) into cell-derived microvesicles (MVs) is regulated by the phosphorylation of the cytoplasmic domain of TF. Since the cytoskeletal protein filamin-A is known to bind to the cytoplasmic domain of TF in a phosphorylation-dependent manner, the involvement of filamin-A in the incorporation of TF into MVs was examined. Endothelial cells were transfected to express TF, whereas MDA-MB-231 cells were used to examine endogenously expressed TF. MV release was induced by activating protease-activated receptor-2 (PAR2). Partial suppression of filamin-A expression using two different filamin-A siRNA sequences resulted in significant reductions in the incorporation of TF antigen into MVs as determined by TF-ELISA and western blot analysis, and was reflected in reduced thrombin-generation and FXa-generation capacities of these MVs. Deletion of the cytoplasmic domain of TF also resulted in reduced incorporation of TF into MVs, whereas the suppression of filamin-A expression had no additional effect on the incorporation of truncated TF into MVs. Partial suppression of filamin-A expression had no effect on the number and size distribution of the released MVs. However, >90% suppression of filamin-A expression resulted in increased MV release, possibly as a result of increased instability of the plasma membrane and underlying cytoskeleton. In conclusion, the presence of filamin-A appears to be essential for the incorporation of TF into MVs following PAR2 activation, but is not required for the process of MV formation and release following PAR2 activation.

 
  • References

  • 1 Kushak RI, Nestoridi E, Lambert J. et al. Detached endothelial cells and microparticles as sources of tissue factor activity.. Thromb Res 2005; 116: 409-419.
  • 2 Shet AS, Aras O, Gupta K. et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.. Blood 2003; 102: 2678-2683.
  • 3 Del Conde I, Shrimpton CN, Thiagarajan P. et al. Tissue-factor-bearing microparticles arise from lipid rafts and fuse with activated platelets to initiate coagulation.. Blood 2005; 106: 1604-1611.
  • 4 Schecter AD, Spirn B, Rossikhina M. et al. Release of active tissue factor by human arterial smooth muscle cells.. Circ Res 2000; 87: 126-132.
  • 5 Zwicker JI, Liebman HA, Neuberg D. et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.. Clin Cancer Res 2009; 15: 6830-6840.
  • 6 Mueller BM, Ruf W. Requirement for binding of catalytically active factor Vila in tissue factor-dependent experimental metastasis.. J Clin Invest 1998; 10: 1372-1378.
  • 7 Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.. J Biol Chem 2004; 279: 23038-23044.
  • 8 Collier ME, Ettelaie C. Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor.. J Biol Chem 2011; 286: 11977-11984.
  • 9 Sapet C, Simoncini S, Loriod B. et al. Thrombin-induced endothelial micropar-ticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2.. Blood 2006; 108: 1868-1876.
  • 10 Morel O, Jesel L, Freyssinet JM. et al. Cellular mechanisms underlying the formation of circulating microparticles.. Arterioscler Thromb Vasc Biol 2011; 31: 15-26.
  • 11 Nakamura F, Stossel TP, Hartwig JH. The filamins: organizers of cell structure and function.. Cell Adh Migr 2011; 5: 160-169.
  • 12 Gorlin JB, Yamin R, Egan S. et al. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring.. J Cell Biol 1990; 111: 1089-1105.
  • 13 Ott I, Fischer EG, Miyagi Y. et al. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.. J Cell Biol 1998; 140: 1241-1253.
  • 14 Collier ME, Ettelaie C. Induction of endothelial cell proliferation by recombi-nant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation.. Arterioscler Thromb Vasc Biol 2010; 30: 1810-1817.
  • 15 Ettelaie C, Su S, Li C. et al. Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells.. Microvasc Res 2008; 76: 152-160.
  • 16 Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A.. Proc Natl Acad Sci USA 2001; 98: 5258-5263.
  • 17 Li M, Bermak JC, Wang ZW. et al. Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280).. Mol Pharmacol 2000; 57: 446-452.
  • 18 Mammoto A, Huang S, Ingber DE. Filamin links cell shape and cytoskeletal structure to Rho regulation by controlling accumulation of p190RhoGAP in lipid rafts.. J Cell Sci 2007; 120: 456-467.
  • 19 Onoprishvili I, Andria ML, Kramer HK, Ancevska-Taneva N, Hiller JM, Simon EJ. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking.. Mol Pharmacol 2003; 64: 1092-1100.
  • 20 Seck T, Baron R, Horne WC. Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling.. J Biol Chem 2003; 278: 10408-10416.
  • 21 Jy W, Jimenez JJ, Mauro LM. et al. Agonist-induced capping of adhesion proteins and microparticle shedding in cultures of human renal microvascular en- dothelial cells.. Endothelium 2002; 9: 179-189.
  • 22 Peña E, Arderiu G, Badimon L. Subcellular localization of tissue factor and human coronary artery smooth muscle cell migration.. J Thromb Haemost 2012; 10: 2373-2382.
  • 23 Davizon P, Munday AD, López JA. Tissue factor, lipid rafts, and microparticles.. Semin Thromb Hemost 2010; 36: 857-864.
  • 24 Mandal SK, Pendurthi UR, Rao LV. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.. Blood 2007; 110: 161-170.
  • 25 Bona R, Lee E, Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles.. Thromb Res 1987; 48: 487-500.
  • 26 Feng S, Lu X, Kroll MH. Filamin A binding stabilizes nascent glycoprotein Ibalpha trafficking and thereby enhances its surface expression.. J Biol Chem 2005; 280: 6709-6715.
  • 27 Kanaji T, Ware J, Okamura T. et al. GPIba regulates platelet size by controlling the subcellular localization of filamin.. Blood 2012; 119: 2906-2913.
  • 28 Legler DF, Doucey MA, Schneider P. et al. Differential insertion of GPI-an-chored GFPs into lipid rafts of live cells.. FASEB J 2005; 19: 73-75.
  • 29 Brown D, Waneck GL. Glycosyl-phosphatidylinositol-anchored membrane proteins.. J Am Soc Nephrol 1992; 3: 895-906.
  • 30 Nasu J, Mizuno M, Uesu T. et al. Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells.. Clin Exp Immuno 1998; 113: 379-385.
  • 31 Cunningham CC, Gorlin JB, Kwiatkowski DJ. et al. Actin-binding protein requirement for cortical stability and efficient locomotion.. Science 1992; 255: 325-327.
  • 32 Jimenez JJ, Jy W, Mauro LM. et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis.. Thromb Res 2003; 109: 175-180.